Works by Almond, Lisa M

Results: 14

PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies.

Published in:

CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13865

By:

Abla, Nada;
Almond, Lisa M.;
Bonner, Jennifer J.;
Richardson, Naomi;
Wells, Timothy N. C.;
Möhrle, Jörg J.

Publication type:

Article

Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals

Published in:

Clinical Pharmacology & Therapeutics, 2005, v. 78, n. 2, p. 132, doi. 10.1016/j.clpt.2005.04.004

By:

Almond, Lisa M.;
Edirisinghe, Damitha;
Dalton, Mark;
Bonington, Alec;
Back, David J.;
Khoo, Saye H.

Publication type:

Article

Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 4, p. 738, doi. 10.1093/jac/dki308

By:

Lisa M. Almond;
Patrick G. Hoggard;
Damitha Edirisinghe;
Saye H. Khoo;
David J. Back

Publication type:

Article

PBPK‐Led Assessment of Antimalarial Drug Concentrations in Breastmilk: A Strategy for Optimal Use of Prediction Methods to Guide Decision Making in an Understudied Population.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 4, p. 738, doi. 10.1002/psp4.13311

By:

Almond, Lisa M.;
Abduljalil, Khaled;
Pansari, Amita;
Kusmider, Beata;
Jones, Hannah M.;
Rowland Yeo, Karen;
Gardner, Iain;
Faisal, Muhammad;
Marrast, Anne Claire;
El Gaaloul, Myriam;
Möhrle, Jörg J.;
Abla, Nada

Publication type:

Article

Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 11, p. 1924, doi. 10.1002/psp4.13251

By:

Ning, Jia;
Pansari, Amita;
Rowland Yeo, Karen;
Heikkinen, Aki T.;
Waitt, Catriona;
Almond, Lisa M.

Publication type:

Article

A tutorial on physiologically based pharmacokinetic approaches in lactation research.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 11, p. 1841, doi. 10.1002/psp4.13232

By:

Pansari, Amita;
Pan, Xian;
Almond, Lisa M.;
Rowland‐Yeo, Karen

Publication type:

Article

Supplementing clinical lactation studies with PBPK modeling to inform drug therapy in lactating mothers: Prediction of primaquine exposure as a case example.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 3, p. 386, doi. 10.1002/psp4.13090

By:

Pan, Xian;
Abduljalil, Khaled;
Almond, Lisa M.;
Pansari, Amita;
Yeo, Karen Rowland

Publication type:

Article

Development and application of a PBPK modeling strategy to support antimalarial drug development.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 9, p. 1335, doi. 10.1002/psp4.13013

By:

Abla, Nada;
Howgate, Eleanor;
Rowland‐Yeo, Karen;
Dickins, Maurice;
Bergagnini‐Kolev, Mackenzie C.;
Chen, Kuan‐Fu;
McFeely, Savannah;
Bonner, Jennifer J.;
Santos, Laura G. A.;
Gobeau, Nathalie;
Burt, Howard;
Barter, Zoe;
Jones, Hannah M.;
Wesche, David;
Charman, Susan A.;
Möhrle, Jörg J.;
Burrows, Jeremy N.;
Almond, Lisa M.

Publication type:

Article

Physiologically‐Based Pharmacokinetic‐Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor‐Tezacaftor‐Ivacaftor With Nirmatrelvir‐Ritonavir for the Treatment of COVID‐19.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 6, p. 1324, doi. 10.1002/cpt.2585

By:

Hong, Eunjin;
Almond, Lisa M.;
Chung, Peter S.;
Rao, Adupa P.;
Beringer, Paul M.

Publication type:

Article

Impact of Disease on Plasma and Lung Exposure of Chloroquine, Hydroxychloroquine and Azithromycin: Application of PBPK Modeling.

Published in:

Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 5, p. 976, doi. 10.1002/cpt.1955

By:

Rowland Yeo, Karen;
Zhang, Mian;
Pan, Xian;
Ban Ke, Alice;
Jones, Hannah M.;
Wesche, David;
Almond, Lisa M.

Publication type:

Article

Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.

Published in:

2011

By:

Ghobadi C;
Johnson TN;
Aarabi M;
Almond LM;
Allabi AC;
Rowland-Yeo K;
Jamei M;
Rostami-Hodjegan A;
Ghobadi, Cyrus;
Johnson, Trevor N;
Aarabi, Mohsen;
Almond, Lisa M;
Allabi, Aurel Constant;
Rowland-Yeo, Karen;
Jamei, Masoud;
Rostami-Hodjegan, Amin

Publication type:

journal article

Application of a Systems Approach to the Bottom-Up Assessment of Pharmacokinetics in Obese Patients.

Published in:

Clinical Pharmacokinetics, 2011, v. 50, n. 12, p. 809, doi. 10.2165/11594420-000000000-00000

By:

Ghobadi, Cyrus;
Johnson, Trevor N.;
Aarabi, Mohsen;
Almond, Lisa M.;
Allabi, Aurel Constant;
Rowland-Yeo, Karen;
Jamei, Masoud;
Rostami-Hodjegan, Amin

Publication type:

Article

Incorporating Population Variability and Susceptible Subpopulations into Dosimetry for High-Throughput Toxicity Testing.

Published in:

Toxicological Sciences, 2014, v. 142, n. 1, p. 210, doi. 10.1093/toxsci/kfu169

By:

Wetmore, Barbara A.;
Allen, Brittany;
Clewell III, Harvey J.;
Parker, Timothy;
Wambaugh, John F.;
Almond, Lisa M.;
Sochaski, Mark A.;
Thomas, Russell S.

Publication type:

Article

Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series.

Published in:

Pharmacotherapy, 2023, v. 43, n. 4, p. 291, doi. 10.1002/phar.2786

By:

Hong, Eunjin;
Li, Regina;
Shi, Alan;
Almond, Lisa M.;
Wang, Joshua;
Khudari, Amin Z.;
Haddad, Soumar;
Sislyan, Sarkis;
Angelich, Marissa;
Chung, Peter S.;
Rao, Adupa P.;
Beringer, Paul M.

Publication type:

Article